Themost common subtype of renal cell carcinoma (RCC) is clear cell RCC (ccRCC) that accounts for 70–80% of all renal malignancies. To date, no useful markers are available in clinical practice for early diagnosis and for optimal patient stratification. MicroRNAs, a class of small non-coding RNA, are emerging as promising molecules in the management of urological tumors suggesting the possibility of using them as non-invasive biomarkers. The aim of this study is to evaluate whether miR-210-3p may be an accurate non invasive diagnostic and prognostic biomarker for ccRCC patients.

Liquid biopsy in clear cell renal cell carcinoma. Urinary miR-210-3p as emerging specific biomarker / Costantini, M.; Petrozza, V.; Tito, C.; Giammusso, L. M.; Sorrentino, V.; Cacciotti, J.; Porta, N.; Iaiza, A.; Pastore, A. L.; Di Carlo, A.; Simone, G.; Gallucci, M.; Carbone, A.; Fazi, F.. - In: EUROPEAN UROLOGY OPEN SCIENCE. - ISSN 2666-1691. - (2020). (Intervento presentato al convegno EAU Virtual Congress 2020 tenutosi a Online) [10.1016/S2666-1683(20)35516-6].

Liquid biopsy in clear cell renal cell carcinoma. Urinary miR-210-3p as emerging specific biomarker

V. Petrozza;C. Tito;V. Sorrentino;N. Porta;A. Iaiza;A. L. Pastore;A. Di Carlo;M. Gallucci;A. Carbone;F. Fazi
2020

Abstract

Themost common subtype of renal cell carcinoma (RCC) is clear cell RCC (ccRCC) that accounts for 70–80% of all renal malignancies. To date, no useful markers are available in clinical practice for early diagnosis and for optimal patient stratification. MicroRNAs, a class of small non-coding RNA, are emerging as promising molecules in the management of urological tumors suggesting the possibility of using them as non-invasive biomarkers. The aim of this study is to evaluate whether miR-210-3p may be an accurate non invasive diagnostic and prognostic biomarker for ccRCC patients.
2020
EAU Virtual Congress 2020
04 Pubblicazione in atti di convegno::04d Abstract in atti di convegno
Liquid biopsy in clear cell renal cell carcinoma. Urinary miR-210-3p as emerging specific biomarker / Costantini, M.; Petrozza, V.; Tito, C.; Giammusso, L. M.; Sorrentino, V.; Cacciotti, J.; Porta, N.; Iaiza, A.; Pastore, A. L.; Di Carlo, A.; Simone, G.; Gallucci, M.; Carbone, A.; Fazi, F.. - In: EUROPEAN UROLOGY OPEN SCIENCE. - ISSN 2666-1691. - (2020). (Intervento presentato al convegno EAU Virtual Congress 2020 tenutosi a Online) [10.1016/S2666-1683(20)35516-6].
File allegati a questo prodotto
File Dimensione Formato  
Costantini_Liquid-biopsy_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 39.67 kB
Formato Adobe PDF
39.67 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1452251
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact